Laurus Labs share price at record high after Q2 results 2026, dividend announcement - Should you buy pharma stock?
Laurus Labs shares hit a record high after Q2FY27 revenue rose 33% and net profit jumped 126%. The company declared an interim dividend and expanded peptide manufacturing. While brokerages recognized growth prospects, they urged investors to weigh potential against the stock’s sharp rally.
Read the full story at Livemint →